Accuray Inc, a radiology oncology technologies company, announced on November 18 that its CyberKnife System is now treating patients in Manhattan at Winthrop University Hospital’s NYCyberKnife Center. Winthrop has installed the latest generation CyberKnife M6 System, which is a dedicated radiosurgery device that delivers precise full-body treatments to cancer patients, while maximizing their quality of life during and after treatment.
The CyberKnife M6 System has full-body radiosurgery capabilities with robotic mobility, which enables it to deliver radiation beams from a wide range of angles around the body, precisely targeting tumors while avoiding healthy tissue. It can be used to treat tumors anywhere in the body, including the prostate, lung, brain, spine, liver, pancreas, and kidney. The treatment delivers high doses of radiation to tumors with extreme accuracy, offering hope to patients who have inoperable or surgically complex tumors, or who prefer a clinically effective, non-surgical option.
“The Winthrop team is excited to be the first center in Manhattan to offer patients requiring radiation therapy the option to receive treatment with the CyberKnife System,” said Jonathan Haas, MD, chief, Division of Radiation Oncology at Winthrop-University Hospital. “We selected the CyberKnife M6 System because it includes the features and precision of the previous model, with the potential to provide faster treatment times, and expand access to more patients.”
According to Accuray, the CyberKnife System’s ability to automatically stay on target despite patient and tumor motion is what differentiates it from other forms of radiation therapy systems. It automatically follows the tumor throughout the treatment process, delivering radiation with sub-millimeter precision. This motion compensation feature helps clinicians to precisely maximize dose, minimize side effects and maximize patient comfort.
For more information about the CyberKnife M6 System, visit the Accuray website.
